The deal helps move BioNTech’s proposed acquisition of CureVac closer to completion. With the settlement, GSK said it will tender the CureVac shares it owns in support of the $1.25 billion acquisition. The post BioNTech to Pay CureVac, GSK $740M Plus Royalties to Settle mRNA Patent Disputes appeared first on MedCity News.
[Sponsored] Pharmacies are under more pressure than ever. Rising prescription volumes, staffing shortages and growing expectations for accuracy and safety have made it clear that the old ways of managing medications are no longer enough. Automation has become the key to keeping pace with modern healthcare. It saves time, reduces errors and helps providers focus…
AI solutions baked into the EHR experience could radically transform the clinical effectiveness of physicians by leveraging the richness of the longitudinal patient record, while also creating efficiencies that give them back more time to care and create more revenue. The post From Paper Charts to AI Scribes: The EHR Revolution appeared first on MedCity…
Check out news from Oral Genome, Carrot Fertility, Thatch, and The Perryman Group. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.
This volume explores narratives linking vaccines to autism and misleading claims about the benefits of raw milk. It examines how trust and perceived expertise influence misinformation and AI’s role in spreading false mental health information.
Reimbursement models that align primary care with behavioral health offer low-income provider organizations serving rural Americans and other vulnerable populations an opportunity to enhance coordination and improve outcomes while generating sorely needed revenue. The post How to Align Primary Care With Behavioral Health appeared first on MedCity News.
Fidelity Management & Research Company and Dexcom participated in ŌURA’s $200 million Series D round. The post ŌURA Snags $200M, Hits $5.2B Valuation appeared first on MedCity News.
This slideshow examines how cost and insurance affects people’s access to care, including decisions to forgo or delay needed care and access to a usual source of care.
During a recent panel discussion, healthcare leaders highlighted that the true promise of technology lies in ensuring that tools are practical, trusted and widely usable for both patients and clinicians. The post What Healthcare Tech Has Leaders Most Energized Right Now? appeared first on MedCity News.
Bain Capital already owns nearly 40 percent of the Tennessee-based company’s stock. An analyst thinks other potential buyers will surface.